Sentences with phrase «product under a patent»

From a legal perspective, you will need to consider whether it is better to protect a product under a patent or as a trade secret.

Not exact matches

These risks and uncertainties include, among others: the unfavorable outcome of litigation, including so - called «Paragraph IV» litigation and other patent litigation, related to any of our products or products using our proprietary technologies, which may lead to competition from generic drug manufacturers; data from clinical trials may be interpreted by the FDA in different ways than we interpret it; the FDA may not agree with our regulatory approval strategies or components of our filings for our products, including our clinical trial designs, conduct and methodologies and, for ALKS 5461, evidence of efficacy and adequacy of bridging to buprenorphine; clinical development activities may not be completed on time or at all; the results of our clinical development activities may not be positive, or predictive of real - world results or of results in subsequent clinical trials; regulatory submissions may not occur or be submitted in a timely manner; the company and its licensees may not be able to continue to successfully commercialize their products; there may be a reduction in payment rate or reimbursement for the company's products or an increase in the company's financial obligations to governmental payers; the FDA or regulatory authorities outside the U.S. may make adverse decisions regarding the company's products; the company's products may prove difficult to manufacture, be precluded from commercialization by the proprietary rights of third parties, or have unintended side effects, adverse reactions or incidents of misuse; and those risks and uncertainties described under the heading «Risk Factors» in the company's most recent Annual Report on Form 10 - K and in subsequent filings made by the company with the U.S. Securities and Exchange Commission («SEC»), which are available on the SEC's website at www.sec.gov.

«Under [Jimenez's] leadership the innovation pipeline was rejuvenated, and we successfully navigated the patent expirations of our two largest products,» Reinhardt said.

Look for companies that start in smaller areas, or have a niche product that is under patent or trademarked.

As industries consolidate and product cycles shrink, even the best ideas — with patents as their pedigrees — come under assault practically on arrival.

Its patented processes and products for food ingredients are commercialised under the Cocoapro trademark.

Under the bill, companies that domestically manufacture products based on U.S. patents will pay a lower corporate tax rate — 15 percent compared to the usual 35 percent.

Ahring's group has previously been successful in using standard Aspergillus fungi to produce enzymes and other useful products, which have been patented and are under commercialization, so they decided to look into A. carbonarius ITEM 5010's potential for biofuels.

CycleBeads and iCycleBeads are patented products based on the scientifically proven Standard Days Method of family planning, manufactured and distributed by Cycle Technologies under license.

Barnes & Noble and Microsoft have settled their patent litigation, and moving forward, Barnes & Noble and Newco will have a royalty - bearing license under Microsoft's patents for its NOOK eReader and Tablet products.

April 30, 2012: Barnes & Noble and Microsoft Form Strategic Partnership to Advance World - Class Digital Reading Experiences for Consumers» («Barnes & Noble and Microsoft have settled their patent litigation, and moving forward, Barnes & Noble and Newco will have a royalty - bearing license under Microsoft's patents for its NOOK eReader and Tablet products.»)

The SturdiBag from Sturdi Products is a flexible - height carrier with a patented design that allows the top to flex without collapsing, allowing the SturdiBag to conform to the under - seat height of all airline seats.

The two did get a patent for their idea under Kenyan law, but they had neither the backers nor the bucks to take the product commercial.

The FCA affirmed the Federal Court's reasoning on product specificity that «the claimed formulation and the approved formulation do not match precisely and the requirement of product specificity is not met» and then considered the «475 Patent under section 4 (2)(a).

In conclusion the FCA upheld the Judge's conclusion that the patent claims fail the requirement for product specificity because they do not make specific reference to the medicinal ingredient rilpirivine, but only the broad class of compounds, but the FCA did so under section 4 (2)(a) rather than 4 (2)(b).

Unless there is the above restriction, the resale of the patented products sold abroad will not infringe the Japanese patent right under the doctrine of implicit licensing by the patent owner.

Have they ever been a defendant in a patent suit by a company that used products that they released under the BSD license?

In a 8 - 0 ruling, the U.S. Supreme Court ruled that damages for infringement of design patents under 35 U.S.C. § 289 can be limited to the defendant's «total profits» from the article of manufacture that contains the patented design, which may only be one component of a commercial product, rather than...

In a 8 - 0 ruling, the U.S. Supreme Court ruled that damages for infringement of design patents under 35 U.S.C. § 289 can be limited to the defendant's «total profits» from the article of manufacture that contains the patented design, which may only be one component of a commercial product, rather than the entire product.

While this decision does not affect design patent damages based on the patent owner's lost profits or a reasonable royalty, it is likely to limit the desirability of seeking the infringer's profits under 35 U.S.C. § 289 in some cases, primarily those involving designs on portions of products.

[9] A jurisdictional issue could also arise in proceedings instituted under the transitional program for covered business method patents based on the PTAB's incorrect interpretation of the terms «financial product or service» or «technological invention.»

While a novel product containing a cannabis derivative as well as cannabis - related processes and methods may be eligible for protection under the Patent Act — such as the production of edibles and concentrates — a cannabis plant itself is not patentable in Canada.

Since joining JAMS, Judge Roberts has been appointed as a discovery master by federal and state courts to supervise discovery and review privileged documents in complex commercial, patent, and product liability cases, as an election monitor for unions under court supervision, as a consultant to monitor a four - year consent decree in an EEOC pattern and practice case against a major restaurant chain, and as a trustee for a 36 - story commercial retail and office building on Fifth Avenue

Licensing Termination Provisions for Under - performing License Agreements After securing a patent on an invention and you are making money, another company may want to use the patented technology in their product or service.

The two companies settle under terms that require (1) Company B, the claimed infringer, not to produce the patented product until the patent's term expires, and (2) Company A, the patentee, to pay B many millions of dollars.

The court unanimously * held that, under 28 U.S.C. § 1400 (b)(the statute governing venue in patent suits), a domestic corporation «resides» only in its state of incorporation, consistent with its ruling in an earlier case, Fourco Glass Co. v. Transmirra Products Corp., 353 U. S. 222 (1957).

Under the contract with Ratiopharm, GSK retained all patent rights to its product.

Myriad (the patentee) argues that it should be able to patent «anything under the sun that is made by man» and that its work in isolating the human gene is a composition that is the «product of human ingenuity».

These situations involve the complicated interactions between the Patented Medicine (Notice of Compliance) Regulations, including damages under Section 8 of those regulations, as well as provincial substitution policies for pharmaceutical products.

An important mention has to be made: not all patents end up under the hoods of the end products, and Apple might just be testing the waters here.

The STOP Act also includes a provision requiring the Patent Office to expand access to pro bono legal services to «under - resourced re-sellers, users, implementers, distributors, or custormers of an allegedly infringing product or process.»

Under H.R. 4829, the ITC would only look at patent disputes where the patent owner actually helped develop the product in the United States.

Co-developed multiple products currently in patent pending status, under patent assignment and awaiting filing.